The Food and Drug Administration on Tuesday approved another bivalent COVID-19 booster dose for older adults and people with weak immune systems in an effort to bolster protection against the virus this spring.

Director of UArizona Health Sciences’ Asthma and Airway Center has deep connection to making sure everyone breathes easier.

The U.S. Supreme Court said Friday it would temporarily keep in place federal regulations for use of mifepristone, while it considers issues raised by a federal judge's ruling that suspended FDA approval of the medication and its use in abortion procedures.

Adding pembrolizumab to chemotherapy with or without bevacizumab can help patients with persistent, recurrent, or metastatic cervical cancer “live longer and better,” according to a study.

Recently, the University of Arizona’s One Health Research Initiative awarded graduate research assistantships to two doctoral students conducting research at the College of Veterinary Medicine.

Comprehensive Pain and Addiction Center researchers are studying how electronic stimulation of the brain can break looping pain signals and destructive cravings.

A University of Arizona Health Sciences study uncovered new ways in which Hsp90-inhibitor drugs in the spinal cord are showing promise as potential pain therapeutics.

Not regulating the synthetic byproducts of hemp-derived products like Delta-8 could result in a public health crisis.

Healthy older adults with unintentional weight loss may die sooner than their counterparts who maintain their weight, a new study suggests.